A new 7000 square meter medical isotope facility – the world’s largest production site of lutetium-177 The ceremony was conducted by Minister of State Dr Florian Herrmann in the presence of other high-ranking guests this medical isotope has gained importance in precision oncology treatments in recent years; once the new NOVA production facility is fully operational ITM will increase its capacity to supply clinics pharmaceutical partners and its own drug pipeline tenfold Describing the facility as an important milestone for the company Head of the State Chancellery and Minister of State for Federal Affairs and Media commented: “As a local member of parliament I am particularly pleased that the production facility is being built here in Neufahrn near Freising This is a strong signal for the community and the entire region we have been supporting the development of ITM practically from the very beginning The Bavarian Research Foundation has already provided financial support for many of the company’s important research projects We will continue to support the research and development of innovative cancer drugs in the future We want Bavaria and Germany to remain international leaders in nuclear medicine in the future." "Radiopharmaceuticals are an essential new class of anti-cancer drugs that have the potential to improve therapy outcomes and quality of life for many patients ITM's additional production site is an important contribution to medical research and drug supply for patients in Germany and worldwide," said Udo J Chairman of the Supervisory Board of ITM and Chairman of the Advisory Board of Vetter Pharma "With the significant expansion of our production capacities we are solidifying our leading market position while as the world’s largest manufacturer of nca (no carrier added) lutetium-177 supporting the growth of the radiopharmaceutical industry globally it is our goal to develop and provide innovative diagnostics and therapeutics for the treatment of cancer patients," added Steffen Schuster CEO of ITM." The excellent regional conditions surrounding our facilities coupled with our strong team and established logistics network will enable the fastest possible delivery of high quality radioisotopes to anywhere in the world." by years of collaboration with the Garching Research Reactor (FRM II) and the Technical University of Munich (TUM) ITM will operate the new production site at NOVA Neufahrn industrial park in addition to its existing manufacturing facility IAZ at the main site in Garching near Munich the facility features a high degree of automation in production and logistics laboratories and offices for use by up to 200 employees for research radiopharmaceutical manufacturing and aseptic production More information online Researchers at the Nanoscience Center in University of Jyväskylä isolated a giant virus which has been name.. The production of a nugget of cultured chicken muscle – around 10 grams – has been made possible in a Japanese-developed bioreactor SETAC Europe ISHM 2025 London Lab Live 2025 Euromedlab 2025 InformEx Zone at CPhl North America This website is using a security service to protect itself from online attacks The action you just performed triggered the security solution There are several actions that could trigger this block including submitting a certain word or phrase You can email the site owner to let them know you were blocked Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page.